Market Research Non-Alcoholic Steatohepatitis (NASH) | Page 3

• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Non-Alcoholic Steatohepatitis (NASH) therapeutics • Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope • Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress Essential Points Covered in Table of Contain Report Introduction Executive Summary Snapshot Market Drivers Market Barriers SWOT Analysis Report Methodology Consulting Services Collaborations & Deal Value Trends Companies collaborations for future developments List of Figures are Companies Collaborations vs. Financial year, 2017 Number of Companies Collaborations, 2017 Collaborations and Upfront Deal Values (In million, $), 2017 Number of Products under Development, 2017 Number of Products under Development by Companies, 2017 Number of Products under Development by Indication, 2017 About us: DiligentMarket is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. We support companies by providing end to end comprehensive solutions to improve their performance and in making long lasting decision for their businesses. We advise leading decision makers on their critical issues and opportunities; Research & Development, Strategy Making, Commercial, Operations, Competitive Intelligence, Competitive Landscaping and Mergers & Acquisition across all the Pharmaand Biotech industries and geographies. We serve our clients by delivering practical and enduring results, and equipping our clients to grow and lead. The pharmaceuticals market is in its growth stage and we are uniquely positioned to successfully endeavor the dimensions of the fast growing market by providing cutting-edge market and pipeline information, to our clients. Connect With us on: [phone] [email protected]